Inputs: momentum, trendVelocity
Momentum 68/100 confirmed by trend velocity 74/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.
Prediction result · Ensemble engineUpdated 3:55 AM
BridgeBio Pharma, Inc. (BBIO) is trading at $74.95, up 5.97% since the previous close and +9.32% over the past week. Price sits above its 50-day average by 6.66%, with price momentum at 68/100 and trend velocity at 74/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is moderate (49/100) and the stock is 44% of the way up its 52-week range. The weighted factor score lands at 72/100 — a neutral signal. Research only, not investment advice.
BridgeBio Pharma, Inc.
Signals are model output from public data, not personalized investment advice.
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
No relevant current headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
BridgeBio Pharma, Inc. (BBIO) is trading at $74.95, up 5.97% since the previous close and +9.32% over the past week. Price sits above its 50-day average by 6.66%, with price momentum at 68/100 and trend velocity at 74/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is moderate (49/100) and the stock is 44% of the way up its 52-week range. The weighted factor score lands at 72/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Momentum 68/100 confirmed by trend velocity 74/100.
Sentiment 50/100 + price 6.0% are both mid-range.
Volume 93/100 above its 20-day average on an up-move — accumulation signature.
Vol regime 49/100 is mid-range — no edge.
Mid-range positioning — no edge from range alone.
Sentiment 50/100 vs week change 9.3% are in agreement — no divergence edge.
Price 6.7% over 50d SMA with momentum confirming — uptrend intact.
Oscillator at 71 — neutral zone.
Momentum 68/100 is not strong enough to confirm a breakout.
News 50/100 and weekly change 9.3% do not create a clean follow-through read.
Volume 93/100 does not show a dry-up signal.
Volatility 49/100 does not give a clean compression read.
Range position 44% is too middle-of-the-road to matter.
Sentiment 50/100 and momentum 68/100 are not aligned enough for a clean read.
Price is above the 50d SMA and both momentum and trend velocity are holding up.
Oscillator at 71 does not show a rebound edge.
Why the ensemble agrees
Counter-trees
Headline titles only, from the publisher named on each card. Each links to the original story.
Key stats
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Not yet scheduled
Estimate
N/A
Actual
$-0.42
As of Nov 1, 10:55 PM ET, the ensemble reads neutral on BBIO — no consensus — 12 of 16 bots holding, with 4 bull, 0 bear and 12 hold votes from 16 specialist bots. Research only, not investment advice.
BBIO was $74.95 on the latest quote (Nov 1, 10:55 PM ET), +5.97% since the previous close. Quotes can be delayed.
Scores run from 0 to 100, with 50 neutral. BBIO shows momentum 68/100, trend velocity 74/100 and volatility risk 49/100, with news sentiment at 50/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.